SequelSEC

ProtoKinetix, Inc. PKTX

Pharmaceutical Preparations · CIK 0001128189 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2014-12-31
Operating income
Unavailable
Fiscal year ended 2014-12-31
Free cash flow
Unavailable
Fiscal year ended 2014-12-31

ProtoKinetix, Inc. (PKTX) reported revenue of $0 and net income of $175 for the fiscal year ended 2014-12-31. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from ProtoKinetix, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

ProtoKinetix, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-312014-09-302014-06-302014-03-31
Revenue$0$0$0$0
Cost of revenueUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailableUnavailableUnavailableUnavailable
Net income$175-$13.96K-$69.35K-$85.35K
Research & development-$1.24K$2.12K$0$12.88K
Weighted-average diluted sharesUnavailableshares 175.66Mshares 171.70Mshares 166.45M
Pretax incomeUnavailableUnavailableUnavailable-$85.35K
Income tax expenseUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailable
General & administrative$57.45K$20.98K$49.00K$14.07K
Selling & marketingUnavailableUnavailableUnavailableUnavailable

Balance

ProtoKinetix, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-312014-09-302014-06-302014-03-31
Cash & equivalentsUnavailableUnavailableUnavailableUnavailable
Total assets$5.81K$14.96K$10.00K$5.43K
Current assets$5.81KUnavailableUnavailableUnavailable
Total liabilities$434.14K$635.47K$616.54K$593.62K
Current liabilitiesUnavailableUnavailableUnavailableUnavailable
Total equity incl. NCI-$428.33K-$620.50K-$606.54K-$588.20K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailable
Accounts receivable$5.50K$2.19K$1.28K$119
GoodwillUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailable$147.69K

Cash flow

ProtoKinetix, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-312014-09-302014-06-302014-03-31
Operating cash flow-$38.79K-$54.19K-$83.92K-$52.34K
Capital expendituresUnavailableUnavailableUnavailableUnavailable
Investing cash flow$0$0$30.00K$0
Financing cash flow$28.25K$58.25K$59.00K$51.00K
Net change in cash-$10.54K$4.06K$5.08K-$1.34K
Stock-based compensationUnavailableUnavailable$0$0
Common dividends paidUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailable

Derived

ProtoKinetix, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-312014-09-302014-06-302014-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailable
Current ratioUnavailableUnavailableUnavailableUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PKTX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-09-03View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-03-28View SEC filing
10-Q · Filed 2024-11-12View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.